The REAL-SEQUENCE Study: a real-life comparative effectiveness of ustekinumab and risankizumab in patients with Crohn’s disease after anti-TNFα failure or intolerance – an IG-IBD Study

Promotore	Giuseppe Privitera, Alessandro Armuzzi
Affiliazione	Humanitas University
E-mail	giuseppe.privitera@humanitas.it, alessandro.armuzzi@hunimed.eu

Data sottomissione CS	01/12/2024
Data approvazione CS	05/02/2025
Data inizio	30/04/2025
Data fine	30/04/2026
Documentazione	Protocollo Sinossi Modulo Consenso Infomato + Privacy Lettera al MMG Case Report Form